4 Concerning Numbers From Tilray's Q3 Results
Tilray (NASDAQ: TLRY) released its latest quarterly results Nov. 12, and it failed to excite investors with another disappointing performance. But it wasn't just the fact that the company posted yet another loss that was worrying. Here are four numbers that should make investors think twice before investing in the stock today.
What's perhaps most surprising about the company's recent earnings is that the adult-use market accounted for less than one-third of Tilray's sales during the quarter. That's the segment of the market that should be driving a lot of the company's growth, and while it's adding to Tilray's top line, it wasn't as strong as investors hoped for. By comparison, Aphria (NYSE: APHA) generated $20 million in adult-use sales during its most recent quarter.
Not only that, but Tilray's hemp sales of $15.7 million were nearly as much as recreational market sales during the quarter. While it's a good thing that Tilray is diversified in its revenue streams, it's surprising to see the gap be as narrow as it is given the strong growth that was expected in the industry.
Source Fool.com
